Cynthia Miller, MD, MPH


The Tripledemic as a Precursor to Stakeholder Alignment under the Quintuple Aim

Infectious disease outbreaks will continue to increase and trying to find strategies to ensure providers are cared for to prevent burnout and shortage staffing is essential if another pandemic arises.

Olivia G. Funk, PharmD


The Next Generation of COVID-19 Vaccines and Boosters

Will there be an answer to keep the continuously evolving virus at bay? Are seasonal combination vaccines the wave of the future?

Dhruv P. Patel, MD


Revisiting Old Foes: Updates on HSV

Herpes simplex viruses are chronic infections that underscore racial and ethnic disparities and are afflicting adolescents in increasing numbers.

Yosef Nissim PharmD, BCIDP


CDC Updates Pneumococcal Conjugate Vaccine Recommendations

The federal agency recommends using either PCV13 or PCV15 as part of a 4-dose series for pediatric patients between the ages of 2-59 months.

Karisma Patel, PharmD, BCPPS, BCIDP


Antimicrobial Stewardship: How to Extend a Solid Handshake

In the latest column from SIDP, handshake stewardship prioritizes face-to-face communication between frontline providers to enable feedback to assess the appropriateness of prescribed antimicrobials.

Megan Chatowsky, PharmD Candidate


Secnidazole Offers Hope as Option for Treating Trichomoniasis in Women

This nitroimidazole antibiotic is shown to be efficacious for this condition.

Kerry LaPlante, PharmD, FCCP, FIDSA, FIDP


Antibiotic Stewardship in Outpatient Care

Although there are challenges for clinical and infectious disease pharmacists when trying to apply this concept, here are some considerations and strategies to employ stewardship in this setting.



340B Drug Pricing Program: What Is It and Why Is It Important?

The 340B program has had a great impact on access to HIV treatment and prevention services in the US.

Joseph Glowacki, DO


Mixed Fungal Brain Abscess

Clinicians review a patient case including diagnosis, treatment, and follow-up.

Jason M. Broderick


MRNA COVID-19 Vaccines and Male Fertility

According to a small study, the Moderna and Pfizer COVID-19 vaccines do not impact male fertility.

Grace McComsey, MD, FIDSA


Multidisciplinary Perspectives on HIV Treatment

A multidisciplinary panel concludes a discussion on best practices for managing patients with HIV in various healthcare settings and overcoming social health disparities.

Jason Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS


COVID-19 Booster Shots and the Future

Key opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.

Geraldine A. Finlay, MD


Identifying Disparities in Sepsis Diagnosis for Unbiased Care

Risk of inaccuracy with pulse oximeters and clinician knowledge gaps in people of color may affect sepsis evaluations and impact treatment plans.

George Loukatos, MD


Future Directions for Managing COVID-19 and Influenza

George Loukatos, MD, shares clinical pearls for the management of the SARS-CoV-2 and influenza viruses.

Subramanya Shyam Ganti, MD, MBBS


Challenges in the Management of Mycobacterium abscessus Complex

This pathogen is the third most frequently isolated nontuberculous mycobacteria seen in the United States. Here is a review of how it presents and treatment options.

Jennifer Cocohoba, PharmD


Contemporary Issues on the Treatment of Women Living with HIV in the US

The increasing presence of multiple non-AIDS comorbidities in women and others living with HIV challenges clinicians to steer away from the approach of optimizing individual chronic conditions but to think more holistically.

Paul Monach, MD, PhD


From Pandemic to Endemic

A research agenda focusing on breakthrough infections, reinfections, severity, and sequelae is needed to inform clinical practice when COVID-19 emphasis shifts from eradication to living with the disease.



So You Made the Decision to Implement Vancomycin AUC Dosing. Now What?

Since the vancomycin guideline update, institutional leaders have been faced with the challenge of implementing and monitoring AUC-guided dosing.

Mary Joyce B. Wingler PHARMD, BCIDP


The ART of Implementing an Antiretroviral Stewardship Program

By addressing ART-related medication errors and increasing linkage to care, antiretroviral stewardship programs can improve management of inpatients with HIV.

Morgan Petronelli


Federal Agencies Work to Make RSV Monoclonal Antibody Immunization Accessible to Families

The FDA and CDC announced the availability of additional doses of nirsevimab-alip for infants at high-risk of infection.

T. Sam Albanesi, MD, MA


An Update on Lenacapavir

This new antiretroviral with a unique mechanism of action may be lifesaving for those with treatment-resistant HIV infection.

Jessica Malaty Rivera, MS


Communication Breakdown: Dissemination of Public Health Information

Imprecise language can fuel infodemics and misinformation and damage public trust.

Nisha Patel, PharmD, BCPS


To Prophylax or not to Prophylax: Preventing CDI

Clinicians look at optimal approaches for trying to avoid Clostridioides difficile infection (CDI).

Alison L. Blackman, PharmD, BCIDP


So You Made the Decision to Implement Vancomycin AUC Dosing. Now What?

Since the vancomycin guideline update, institutional leaders have been faced with the challenge of implementing and monitoring AUC-guided dosing.

Ashley L. O’Leary, PHARMD, AAHIVP


Outpatient Antimicrobial Stewardship: The Keys to Developing a Successful Program

This form of stewardship can reduce unnecessary antibiotic prescribing, reduce costs, and optimize patient outcomes.

Brandon Dionne, PharmD, BCPS-AQ ID, BCIDP, AAHIVP


Going Viral on Social Media: Integrating Digital Tools into Pharmacy Rotations

In the latest Bench to Bedside column, 2 clinicians discuss the benefits of utilizing social media for learning.

© 2024 MJH Life Sciences

All rights reserved.